RhumbLine Advisers’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.97M | Buy |
|
|||||
|
2025
Q1 | $2.59M | Sell |
|
|||||
|
2024
Q4 | $3.88M | Buy |
|
|||||
|
2024
Q3 | $5.53M | Sell |
|
|||||
|
2024
Q2 | $4.52M | Buy |
|
|||||
|
2024
Q1 | $3.53M | Buy |
|
|||||
|
2023
Q4 | $3.58M | Sell |
|
|||||
|
2023
Q3 | $3.49M | Buy |
|
|||||
|
2023
Q2 | $4.78M | Buy |
|
|||||
|
2023
Q1 | $3.37M | Buy |
|
|||||
|
2022
Q4 | $3.98M | Buy |
|
|||||
|
2022
Q3 | $3.93M | Buy |
|
|||||
|
2022
Q2 | $3.46M | Buy |
|
|||||
|
2022
Q1 | $3.13M | Buy |
|
|||||
|
2021
Q4 | $4.31M | Sell |
|
|||||
|
2021
Q3 | $4.91M | Buy |
|
|||||
|
2021
Q2 | $7.44M | Buy |
|
|||||
|
2021
Q1 | $4.09M | Sell |
|
|||||
|
2020
Q4 | $6.67M | Buy |
|
|||||
|
2020
Q3 | $2.83M | Sell |
|
|||||
|
2020
Q2 | $2.2M | Buy |
|
|||||
|
2020
Q1 | $1.15M | Buy |
|
|||||
|
2019
Q4 | $1.11M | Buy |
|
|||||
|
2019
Q3 | $961K | Sell |
|
|||||
|
2019
Q2 | $1.32M | Buy |
|
|||||
|
2019
Q1 | $1.4M | Sell |
|
|||||
|
2018
Q4 | $1.26M | Buy |
|
|||||
|
2018
Q3 | $829K | Buy |
|
|||||
|
2018
Q2 | $247K | Buy |
|
|||||
|
2018
Q1 | $274K | Buy |
|